
Overview
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner.
Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC).
Dr. Worden is board certified in Medical Oncology. He is actively involved in clinical research, co-authoring 197 peer reviewed articles and participating in 22 clinical trials. Dr. Worden is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor B1 Reception A, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Worden has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
22 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is an Oncologist and a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Scott Schuetze is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma. Dr. Schuetze is currently accepting new patients.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Rogel Cancer Center
The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is highly rated in 24 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Wilcox is currently accepting new patients.
Rogel Cancer Center
Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology. Dr. Kalemkerian is currently accepting new patients.
University Of Michigan Medical Center
Ajjai Alva is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Alva is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Lymphadenectomy, and Nephrectomy. Dr. Alva is currently accepting new patients.
Frequently Asked Questions about Dr. Francis P. Worden
How do I make an appointment with Dr. Francis P. Worden?
You can book an appointment with Dr. Francis P. Worden by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Francis P. Worden a top-rated expert for Laryngeal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Francis P. Worden is classified as an Elite expert for Laryngeal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Francis P. Worden specialize in?
While Dr. Francis P. Worden is a Hematology, they have specific expertise in Laryngeal Cancer, Throat Cancer, and Thyroid Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Francis P. Worden participate in research or clinical trials?
Yes. Dr. Francis P. Worden has published 197 articles and abstracts on conditions like Laryngeal Cancer. You can view a list of Dr. Francis P. Worden's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Francis P. Worden accept my insurance?
Dr. Francis P. Worden accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adenoid Cystic CarcinomaDr. Worden isElite. Learn about Adenoid Cystic Carcinoma.
- Adrenocortical CarcinomaDr. Worden isElite. Learn about Adrenocortical Carcinoma.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Laryngeal CancerDr. Worden isElite. Learn about Laryngeal Cancer.
- Throat CancerDr. Worden isElite. Learn about Throat Cancer.
- Thyroid CancerDr. Worden isElite. Learn about Thyroid Cancer.
- Distinguished
- Adrenal CancerDr. Worden isDistinguished. Learn about Adrenal Cancer.
- Anaplastic Thyroid CancerDr. Worden isDistinguished. Learn about Anaplastic Thyroid Cancer.
- Follicular Thyroid CancerDr. Worden isDistinguished. Learn about Follicular Thyroid Cancer.
- Hereditary NeuroblastomaDr. Worden isDistinguished. Learn about Hereditary Neuroblastoma.
- Medullary Thyroid CarcinomaDr. Worden isDistinguished. Learn about Medullary Thyroid Carcinoma.
- Nasopharyngeal CarcinomaDr. Worden isDistinguished. Learn about Nasopharyngeal Carcinoma.
- NeuroblastomaDr. Worden isDistinguished. Learn about Neuroblastoma.
- Neuroendocrine TumorDr. Worden isDistinguished. Learn about Neuroendocrine Tumor.
- Papillary Thyroid CancerDr. Worden isDistinguished. Learn about Papillary Thyroid Cancer.
- Salivary Gland TumorsDr. Worden isDistinguished. Learn about Salivary Gland Tumors.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Basal Cell Skin CancerDr. Worden isAdvanced. Learn about Basal Cell Skin Cancer.
- Bone TumorDr. Worden isAdvanced. Learn about Bone Tumor.
- Eccrine PorocarcinomaDr. Worden isAdvanced. Learn about Eccrine Porocarcinoma.
- Epithelial-Myoepithelial Carcinoma
- Ewing SarcomaDr. Worden isAdvanced. Learn about Ewing Sarcoma.
- GliomaDr. Worden isAdvanced. Learn about Glioma.
- Glomus Jugulare TumorDr. Worden isAdvanced. Learn about Glomus Jugulare Tumor.
- Glomus Tympanum TumorDr. Worden isAdvanced. Learn about Glomus Tympanum Tumor.
- Olfactory NeuroblastomaDr. Worden isAdvanced. Learn about Olfactory Neuroblastoma.
- Oral Squamous Cell CarcinomaDr. Worden isAdvanced. Learn about Oral Squamous Cell Carcinoma.
- Penile CancerDr. Worden isAdvanced. Learn about Penile Cancer.
- Polymorphous Low Grade Adenocarcinoma
- Sinus CancerDr. Worden isAdvanced. Learn about Sinus Cancer.
- Squamous Cell Skin CarcinomaDr. Worden isAdvanced. Learn about Squamous Cell Skin Carcinoma.
- TeratocarcinosarcomaDr. Worden isAdvanced. Learn about Teratocarcinosarcoma.
- Tongue CancerDr. Worden isAdvanced. Learn about Tongue Cancer.
- Experienced
- Adrenal Insufficiency PediatricDr. Worden isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Adult Soft Tissue SarcomaDr. Worden isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Worden isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Worden isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Anal CancerDr. Worden isExperienced. Learn about Anal Cancer.
- AnemiaDr. Worden isExperienced. Learn about Anemia.
- Angiosarcoma of the ScalpDr. Worden isExperienced. Learn about Angiosarcoma of the Scalp.
- Brain TumorDr. Worden isExperienced. Learn about Brain Tumor.
- Carcinoid SyndromeDr. Worden isExperienced. Learn about Carcinoid Syndrome.
- CHARGE SyndromeDr. Worden isExperienced. Learn about CHARGE Syndrome.
- Childhood Iron Deficiency AnemiaDr. Worden isExperienced. Learn about Childhood Iron Deficiency Anemia.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Worden isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- ChondrosarcomaDr. Worden isExperienced. Learn about Chondrosarcoma.
- Chromophobe Renal Cell CarcinomaDr. Worden isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Worden isExperienced. Learn about Clear Cell Sarcoma.
- Cushing's syndrome due to Adrenal TumorDr. Worden isExperienced. Learn about Cushing's syndrome due to Adrenal Tumor.
- Deep Vein ThrombosisDr. Worden isExperienced. Learn about Deep Vein Thrombosis.
- DiarrheaDr. Worden isExperienced. Learn about Diarrhea.
- Ear CancerDr. Worden isExperienced. Learn about Ear Cancer.
- Early Infantile Epileptic Encephalopathy
- EGFR Positive Lung CancerDr. Worden isExperienced. Learn about EGFR Positive Lung Cancer.
- Epithelioid SarcomaDr. Worden isExperienced. Learn about Epithelioid Sarcoma.
- Familial Colorectal CancerDr. Worden isExperienced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Worden isExperienced. Learn about Familial Pancreatic Cancer.
- Familial Wilms Tumor 2Dr. Worden isExperienced. Learn about Familial Wilms Tumor 2.
- FibrosarcomaDr. Worden isExperienced. Learn about Fibrosarcoma.
- Gallbladder AdenocarcinomaDr. Worden isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Worden isExperienced. Learn about Gallbladder Cancer.
- GanglioneuroblastomaDr. Worden isExperienced. Learn about Ganglioneuroblastoma.
- GanglioneuromaDr. Worden isExperienced. Learn about Ganglioneuroma.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Gastroesophageal Junction CancerDr. Worden isExperienced. Learn about Gastroesophageal Junction Cancer.
- Gastrointestinal Stromal TumorDr. Worden isExperienced. Learn about Gastrointestinal Stromal Tumor.
- Gilbert SyndromeDr. Worden isExperienced. Learn about Gilbert Syndrome.
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- HypertensionDr. Worden isExperienced. Learn about Hypertension.
- JaundiceDr. Worden isExperienced. Learn about Jaundice.
- Koolen De Vries SyndromeDr. Worden isExperienced. Learn about Koolen De Vries Syndrome.
- Lacrimal Gland TumorDr. Worden isExperienced. Learn about Lacrimal Gland Tumor.
- Large-Cell Lung CarcinomaDr. Worden isExperienced. Learn about Large-Cell Lung Carcinoma.
- LiposarcomaDr. Worden isExperienced. Learn about Liposarcoma.
- Lung AdenocarcinomaDr. Worden isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Worden isExperienced. Learn about Lung Cancer.
- Lung NodulesDr. Worden isExperienced. Learn about Lung Nodules.
- Lymphofollicular HyperplasiaDr. Worden isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lynch SyndromeDr. Worden isExperienced. Learn about Lynch Syndrome.
- MalnutritionDr. Worden isExperienced. Learn about Malnutrition.
- MelanomaDr. Worden isExperienced. Learn about Melanoma.
- Melanoma of the EyeDr. Worden isExperienced. Learn about Melanoma of the Eye.
- MesenchymomaDr. Worden isExperienced. Learn about Mesenchymoma.
- Metastatic Brain TumorDr. Worden isExperienced. Learn about Metastatic Brain Tumor.
- Microcephaly Deafness SyndromeDr. Worden isExperienced. Learn about Microcephaly Deafness Syndrome.
- Multiple Endocrine NeoplasiaDr. Worden isExperienced. Learn about Multiple Endocrine Neoplasia.
- Myxoid LiposarcomaDr. Worden isExperienced. Learn about Myxoid Liposarcoma.
- Newborn JaundiceDr. Worden isExperienced. Learn about Newborn Jaundice.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Worden isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Obesity in ChildrenDr. Worden isExperienced. Learn about Obesity in Children.
- Opioid Induced ConstipationDr. Worden isExperienced. Learn about Opioid Induced Constipation.
- OsteosarcomaDr. Worden isExperienced. Learn about Osteosarcoma.
- Pancreatic CancerDr. Worden isExperienced. Learn about Pancreatic Cancer.
- PheochromocytomaDr. Worden isExperienced. Learn about Pheochromocytoma.
- Pituitary TumorDr. Worden isExperienced. Learn about Pituitary Tumor.
- Pleuropulmonary BlastomaDr. Worden isExperienced. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Worden isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Worden isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Pseudomyxoma PeritoneiDr. Worden isExperienced. Learn about Pseudomyxoma Peritonei.
- Pulmonary EmbolismDr. Worden isExperienced. Learn about Pulmonary Embolism.
- Renal Cell Carcinoma (RCC)Dr. Worden isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Rhabdoid TumorDr. Worden isExperienced. Learn about Rhabdoid Tumor.
- Rhabdoid Tumor Predisposition SyndromeDr. Worden isExperienced. Learn about Rhabdoid Tumor Predisposition Syndrome.
- RhabdomyosarcomaDr. Worden isExperienced. Learn about Rhabdomyosarcoma.
- Rhabdomyosarcoma EmbryonalDr. Worden isExperienced. Learn about Rhabdomyosarcoma Embryonal.
- Secondary Adrenal InsufficiencyDr. Worden isExperienced. Learn about Secondary Adrenal Insufficiency.
- Small Cell Lung Cancer (SCLC)Dr. Worden isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Squamous Cell Lung CarcinomaDr. Worden isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Stomach CancerDr. Worden isExperienced. Learn about Stomach Cancer.
- Synovial SarcomaDr. Worden isExperienced. Learn about Synovial Sarcoma.
- Undifferentiated Pleomorphic SarcomaDr. Worden isExperienced. Learn about Undifferentiated Pleomorphic Sarcoma.
- Viral GastroenteritisDr. Worden isExperienced. Learn about Viral Gastroenteritis.
- Wildervanck SyndromeDr. Worden isExperienced. Learn about Wildervanck Syndrome.
- Wilms TumorDr. Worden isExperienced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Worden isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.




